Featured Research

from universities, journals, and other organizations

Excess Thiamine May Help Tumor Growth, Research Shows

June 23, 1998
Ohio State University
Vitamin B1, which is usually given in excess to many cancer patients, should be carefully regulated in people undergoing cancer therapy, new research shows.

COLUMBUS, Ohio -- Vitamin B1, which is usually given in excess to many cancer patients, should be carefully regulated in people undergoing cancer therapy, new research shows.

Related Articles

The findings reveal a long overlooked link between vitamin B1 -- also known as thiamine -- and tumor-cell growth. The results suggest that too much thiamine may actually help tumors grow. They also suggest that rational use of dietary thiamine may help slow tumor growth.

Thiamine supplementation is commonly recommended to cancer patients to counteract vitamin B1 deficiencies that can occur with leukemias, gastrointestinal tumors, and other faster-growing malignancies. Thiamine deficiency is also a side effect of some kinds of chemotherapy.

Severe thiamine deficiencies can lead to nervous system and memory impairment, and the build-up of lactic acid in the blood.

Thiamine supplementation is therefore often essential for cancer patients. However, total thiamine levels in a patient’s diet can be 250 to 20,000 percent of the normal daily recommended allowance. The government recommends that men consume 1.4 mg and women 1.0 mg of thiamine per day, amounts that are easily obtained from a typical American diet. Medical texts recommend 3 mg of thiamine daily for cancer patients, a dose that needs to be re-evaluated in light of this new research.

Physicians normally don’t worry about excess thiamine because the vitamin is water-soluble, and the body eliminates what it doesn’t need. This study indicates, however, that excess thiamine may contribute to tumor-cell proliferation and to the development of chemotherapy resistance by tumors.

“Cancer patients should be evaluated for their thiamine status, and supplementation should be administered only to meet the patient’s needs,” said Laszlo Boros, a research scientist in the Department of Surgery at Ohio State University.

The study by Boros and an interdisciplinary research team appears in a recent issue of Anticancer Research.

The link between thiamine and cancer was first discovered by Laszlo and the research team last year. That study (published in Cancer Research) revealed that rapidly dividing cancer cells produce a sugar known as ribose that forms the backbone of DNA and RNA using a chemical pathway that is more intensively used by cancer cells than by healthy cells.

Normally, cells produce ribose using a pathway that requires oxygen. Consequently, it is known as the oxidative pathway.

Cancer cells appear to produce ribose using a second pathway, one that doesn’t require oxygen. It is known as the transketolase, or TK, pathway. Transketolase is an enzyme that allows this chemical reaction to happen rapidly and without need of oxygen.

“The majority -- over 70 percent -- of ribose for DNA/RNA synthesis in tumor cells that have been studied comes from the TK pathway,” said Boros. “Nobody expected this pathway to be involved in this process so intensively.”

Furthermore, thiamine is key to that process: the vitamin is a co-factor that is necessary for the transketolase enzyme to work, said Boros. “It’s a thiamine-dependent reaction.”

The discovery led the research team to search the medical literature for other reports of a link between the TK pathway and cancer. They found only one: a 1958 paper that first described the pathway in tumor cells.

“This early observation seems to have been overlooked,” said Boros. “There is no follow-up data in the medical literature describing this pathway in cancer cells and the role of thiamine in the tumor-cell proliferation process.”

Cancer cells favor the TK pathway because it produces ribose molecules faster than the oxidative pathway -- and ribose molecules are in constant demand by rapidly dividing cancer cells for the production of new DNA and RNA.

“When it comes to tumor-cell growth, virus infections, and other conditions that require rapid DNA/RNA synthesis, cells will use the transketolase pathway.”

The ideal solution is to provide thiamine to the patient but deny it to the tumor.

“This could represent a new strategy to control tumor growth,” said W. Scott Melvin, assistant professor of surgery and senior author on the study. “It might be done in the future perhaps through a combination of thiamine restriction and the use of drugs that inhibit the TK pathway.” Such drugs are not yet available for use in humans, however.

“Right now, we’re trying to lay down guidelines to prevent oversupplying thiamine, without letting patients slip into thiamine deficiency,” said Boros, “and we want to emphasize the need to develop TK inhibitors for the treatment of cancer.”

Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.

Cite This Page:

Ohio State University. "Excess Thiamine May Help Tumor Growth, Research Shows." ScienceDaily. ScienceDaily, 23 June 1998. <www.sciencedaily.com/releases/1998/06/980623044807.htm>.
Ohio State University. (1998, June 23). Excess Thiamine May Help Tumor Growth, Research Shows. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/1998/06/980623044807.htm
Ohio State University. "Excess Thiamine May Help Tumor Growth, Research Shows." ScienceDaily. www.sciencedaily.com/releases/1998/06/980623044807.htm (accessed March 31, 2015).

Share This

More From ScienceDaily

More Health & Medicine News

Tuesday, March 31, 2015

Featured Research

from universities, journals, and other organizations

Featured Videos

from AP, Reuters, AFP, and other news services

Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.


Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News


Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile

Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins